Assertio Holdings (ASRT) Interest Expenses (2019 - 2026)

Assertio Holdings' (ASRT) quarterly Interest Expenses came in at $775000.0 in Q1 2026, up 1.31% year-on-year from $765000.0 in Q1 2025, and little changed quarter-over-quarter from $772000.0 in Q4 2025.

Assertio Holdings (ASRT) Interest Expenses (2019 - 2026) Analysis & Trends

Assertio Holdings has disclosed Interest Expenses across 8 years of filings, most recently posting $775000.0 for Q1 2026.

  • Interest Expenses for Q1 2026 came in at $775000.0, up 1.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (up 1.25% YoY), and the FY2025 annual result was $3.1 million, up 1.18% from the prior year.
  • Interest Expenses came in at $775000.0 for Q1 2026 at Assertio Holdings, roughly flat from $772000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $9.9 million in Q1 2023 to a low of $758000.0 in Q2 2024.
  • The 5-year median for Interest Expenses is $769000.0 (2025), against an average of $1.8 million.
  • Across the five-year window, Interest Expenses retreated 13.3% in 2022 and jumped 326.21% in 2023, its largest moves.
  • Assertio Holdings' Interest Expenses stood at $2.3 million in 2022, then surged by 326.21% to $9.9 million in 2023, then plunged by 92.31% to $763000.0 in 2024, then grew by 1.18% to $772000.0 in 2025, then climbed by 0.39% to $775000.0 in 2026.
  • The last three Interest Expenses figures came in at $775000.0 (Q1 2026), $772000.0 (Q4 2025), and $770000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 62.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 3.00 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 20.89 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 4.86 Mn
10 Assertio Holdings 150.94 Mn 79.37 Mn 7.22 Mn 775,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 775,000.00
Mar 31, 2026 775,000.00
Dec 31, 2025 772,000.00
Dec 31, 2025 772,000.00
Sep 30, 2025 770,000.00
Sep 30, 2025 770,000.00
Jun 30, 2025 768,000.00
Jun 30, 2025 768,000.00
Mar 31, 2025 765,000.00
Mar 31, 2025 765,000.00
Dec 31, 2024 763,000.00
Dec 31, 2024 763,000.00
Sep 30, 2024 761,000.00
Sep 30, 2024 761,000.00
Jun 30, 2024 758,000.00
Jun 30, 2024 758,000.00
Mar 31, 2023 9.92 Mn
Mar 31, 2023 9.92 Mn
Mar 31, 2022 2.33 Mn
Mar 31, 2022 2.33 Mn